PROVIDER PROFILE · NPI 1811050594
Mheja Williams
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
1,267
Beneficiaries
—
Total drug cost
$47K
Distinct drugs
35
Brand share
13.9%
Top prescribed drugs
Atorvastatin Calcium159 claims
Amlodipine Besylate136 claims
Omeprazole67 claims
Lisinopril66 claims
Furosemide59 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$14
Payment records
1
By payment type
Food and Beverage$14
Top paying entities
Food and Beverage$14
REFERRAL NETWORK
Where Mheja Williams's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| SLOCUM-RADSON MEDICAL LABORATORIES INC. | 38 | 320 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL | 25 | 68 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE